ABT Abbott Laboratories

Fundamentals / CIK 0000001800 / USD

Abbott Laboratories reported $48.23B in revenue and net income of $4.70B for the trailing twelve months ended September 30, 2026 (up 14.5% year over year), with a 56.9% gross margin and a 13.8% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ABT in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$43.69B$21.84B$0FY 2016 Revenue: $20.85BFY 2016 Net Income: $1.40B2016FY 2017 Revenue: $27.39BFY 2017 Net Income: $477.0M2017FY 2018 Revenue: $30.58BFY 2018 Net Income: $2.37B2018FY 2019 Revenue: $31.90BFY 2019 Net Income: $3.69B2019FY 2020 Revenue: $34.61BFY 2020 Net Income: $4.50B2020FY 2021 Revenue: $43.08BFY 2021 Net Income: $7.07B2021FY 2022 Revenue: $43.65BFY 2022 Net Income: $6.93B2022FY 2023 Revenue: $40.11BFY 2023 Net Income: $5.72B2023FY 2024 Revenue: $41.95BFY 2024 Net Income: $13.40B2024FY 2025 Revenue: $44.33BFY 2025 Net Income: $6.52B2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $44.33B $41.95B $40.11B $43.65B $43.08B $34.61B $31.90B $30.58B $27.39B $20.85B
Cost of Revenue $19.32B $18.71B $17.98B $19.14B $18.54B $15.00B $13.23B $12.71B $12.41B $9.09B
Gross Profit $25.01B $23.24B $22.13B $24.51B $24.54B $19.61B $18.67B $17.87B $14.98B $11.76B
Research & Development $2.94B $2.84B $2.74B $2.89B $2.74B $2.42B $2.44B $2.30B $2.26B $1.45B
Selling, General & Admin $12.33B $11.70B $10.95B $11.25B $11.32B $9.70B $9.77B $9.74B $9.18B $6.74B
Operating Income $8.05B $6.83B $6.48B $8.36B $8.43B $5.36B $4.53B $3.65B $1.56B $3.03B
EBITDA $11.17B $10.04B $9.72B $11.63B $11.96B $8.68B $7.55B $6.93B $4.58B $4.38B
Interest Income $308.0M $344.0M $385.0M $183.0M $43.00M $46.00M $94.00M $105.0M $124.0M $99.00M
Interest Expense $493.0M $559.0M $637.0M $558.0M $533.0M $546.0M $670.0M $826.0M $904.0M $431.0M
Income Before Tax $8.47B $7.01B $6.66B $8.31B $8.21B $4.97B $4.08B $2.87B $2.23B $1.41B
Income Tax Expense $1.94B -$6.39B $941.0M $1.37B $1.14B $497.0M $390.0M $539.0M $1.88B $350.0M
Net Income $6.52B $13.40B $5.72B $6.93B $7.07B $4.50B $3.69B $2.37B $477.0M $1.40B
Basic EPS $3.73 $7.67 $3.28 $3.94 $3.97 $2.52 $2.07 $1.34 $0.27 $0.94
Diluted EPS $3.72 $7.64 $3.26 $3.91 $3.94 $2.50 $2.06 $1.33 $0.27 $0.94
Basic Shares Outstanding 1.74B 1.74B 1.74B 1.75B 1.77B 1.77B 1.77B 1.76B 1.74B 1.48B
Diluted Shares Outstanding 1.75B 1.75B 1.75B 1.76B 1.79B 1.79B 1.78B 1.77B 1.75B 1.48B

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $13.01B $12.59B $11.16B $11.46B $11.37B $11.14B $10.36B $10.97B
Cost of Revenue $5.63B $5.33B $4.89B $4.92B $5.08B $4.85B $4.47B $4.94B
Gross Profit $7.38B $7.27B $6.27B $6.54B $6.29B $6.29B $5.89B $6.03B
Research & Development $920.0M $892.0M $767.0M $735.0M $766.0M $725.0M $716.0M $749.0M
Selling, General & Admin $4.27B $4.03B $3.74B $3.13B $3.05B $3.09B $3.06B $2.91B
Operating Income $1.36B $1.69B $1.34B $2.25B $2.06B $2.05B $1.69B $1.91B
EBITDA $2.61B $2.75B $2.15B $3.04B $2.85B $2.83B $2.45B $2.72B
Interest Income $53.00M $52.00M $106.0M $78.00M $77.00M $71.00M $82.00M $91.00M
Interest Expense $350.0M $351.0M $174.0M $120.0M $121.0M $121.0M $131.0M $136.0M
Income Before Tax $1.23B $1.52B $1.45B $2.36B $2.18B $2.15B $1.78B $2.03B
Income Tax Expense $311.0M $596.0M $372.0M $582.0M $536.0M $371.0M $453.0M -$7.20B
Net Income $920.0M $928.0M $1.08B $1.78B $1.64B $1.78B $1.32B $9.23B
Basic EPS $0.53 $0.53 $0.62 -- $0.94 $1.02 $0.76 --
Diluted EPS $0.53 $0.53 $0.61 -- $0.94 $1.01 $0.76 --
Basic Shares Outstanding 1.73B 1.74B 1.74B -- 1.74B 1.74B 1.74B --
Diluted Shares Outstanding 1.74B 1.74B 1.75B -- 1.75B 1.75B 1.75B --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $8.52B $7.62B $6.90B $9.88B $9.80B $6.84B $3.86B $3.84B $9.41B $18.62B
Short-Term Investments $417.0M $351.0M $383.0M $288.0M $450.0M $310.0M $280.0M $242.0M $203.0M $155.0M
Cash & Short-Term Investments $8.94B $7.97B $7.28B $10.17B $10.25B $7.15B $4.14B $4.09B $9.61B $18.77B
Accounts Receivable, Net $7.93B $6.92B $6.57B $6.22B $6.49B $6.41B $5.42B $5.18B $5.25B $3.25B
Inventory $6.49B $6.19B $6.57B $6.17B $5.16B $5.01B $4.32B $3.80B $3.60B $2.43B
Other Current Assets -- -- -- -- -- -- -- -- $1.67B $1.81B
Total Current Assets $26.00B $23.66B $22.67B $25.22B $24.24B $20.44B $15.67B $14.63B $20.15B $26.78B
Property, Plant & Equipment, Net $11.82B $10.66B $10.15B $9.16B $8.96B $9.03B $8.04B $7.56B $7.61B $5.71B
Goodwill $24.04B $23.11B $23.68B $22.80B $23.23B $23.74B $23.20B $23.25B $24.02B $7.68B
Intangible Assets $5.53B $6.65B $8.81B $10.45B $12.74B $14.78B $17.02B $18.94B $21.47B $4.54B
Long-Term Investments $918.0M $886.0M $799.0M $766.0M $816.0M $821.0M $883.0M $897.0M $883.0M $2.95B
Total Non-Current Assets $60.72B $57.76B $50.54B $49.21B $50.96B $52.11B $52.22B $52.54B $56.10B $25.89B
Total Assets $86.71B $81.41B $73.21B $74.44B $75.20B $72.55B $67.89B $67.17B $76.25B $52.67B
Accounts Payable $4.24B $4.20B $4.29B $4.61B $4.41B $3.95B $3.25B $2.98B $2.40B $1.18B
Short-Term Debt $3.03B $1.50B $1.08B $2.25B $754.0M $220.0M $1.48B $207.0M $714.0M $1.32B
Total Current Liabilities $16.50B $14.16B $13.84B $15.49B $13.11B $11.91B $10.86B $9.01B $8.91B $6.66B
Long-Term Debt $9.90B $12.62B $13.60B $14.52B $17.30B $18.53B $16.66B $19.36B $27.21B $20.68B
Other Non-Current Liabilities $2.54B $2.59B $3.47B $3.80B $3.69B -- -- -- $9.03B $4.55B
Total Non-Current Liabilities $17.45B $19.36B $20.55B $22.04B $26.07B $27.64B $25.72B $27.44B $36.24B $25.29B
Total Liabilities $33.94B $33.51B $34.39B $37.53B $39.17B $39.55B $36.59B $36.45B $45.15B $31.95B
Total Debt (incl. Leases) $14.14B $15.28B $15.87B $17.95B $19.25B $19.89B $19.10B $19.57B $27.92B $22.01B
Common Stock $25.53B $25.15B $24.87B $24.71B $24.47B $24.14B $23.85B $23.51B $23.21B $13.03B
Retained Earnings $49.78B $47.26B $37.55B $35.26B $31.53B $27.63B $25.85B $24.56B $23.98B $25.57B
Accumulated Other Comp. Income -$6.00B -$7.91B -$7.84B -$8.05B -$8.37B -$8.95B -$8.46B -$7.59B -$6.06B -$7.26B
Total Stockholders' Equity $52.13B $47.66B $38.60B $36.69B $35.80B $32.78B $31.09B $30.52B $30.90B $20.54B
Total Equity $52.77B $47.90B $38.83B $36.91B $36.02B $33.00B $31.30B $30.72B $31.10B $20.72B

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $4.05B $5.10B $6.80B $8.52B $7.51B $6.95B $6.53B $7.62B
Short-Term Investments $246.0M $499.0M $492.0M $417.0M $222.0M $331.0M $312.0M $351.0M
Cash & Short-Term Investments $4.30B $5.60B $7.29B $8.94B $7.73B $7.28B $6.84B $7.97B
Accounts Receivable, Net $9.03B $8.60B $8.21B $7.93B $8.14B $7.97B $7.33B $6.92B
Inventory $7.34B $7.32B $6.99B $6.49B $6.71B $6.95B $6.64B $6.19B
Total Current Assets $23.50B $24.52B $25.51B $26.00B $24.84B $24.47B $23.15B $23.66B
Property, Plant & Equipment, Net $12.88B $12.81B $12.38B $11.82B $11.50B $11.39B $10.93B $10.66B
Goodwill $32.64B $35.24B $35.22B $24.04B $23.97B $23.95B $23.36B $23.11B
Intangible Assets $19.59B $17.21B $17.88B $5.53B $5.60B $5.92B $6.26B $6.65B
Long-Term Investments $1.10B $1.11B $1.09B $918.0M $951.0M $958.0M $907.0M $886.0M
Total Non-Current Assets $84.75B $84.70B $84.92B $60.72B $59.34B $59.53B $58.30B $57.76B
Total Assets $108.2B $109.2B $110.4B $86.71B $84.18B $84.00B $81.45B $81.41B
Accounts Payable $4.66B $4.79B $4.68B $4.24B $4.12B $4.31B $4.21B $4.20B
Short-Term Debt $1.71B $3.00B $4.41B $3.03B $1.34B $507.0M $506.0M $1.50B
Total Current Liabilities $16.15B $17.81B $18.38B $16.50B $14.58B $13.44B $13.00B $14.16B
Long-Term Debt $29.45B $29.60B $29.64B $9.90B $11.60B $12.93B $12.74B $12.62B
Other Non-Current Liabilities -- -- -- $2.54B -- -- -- $2.59B
Total Non-Current Liabilities $40.47B $39.64B $39.35B $17.45B $18.34B $19.73B $19.38B $19.36B
Total Liabilities $56.62B $57.45B $57.73B $33.94B $32.92B $33.17B $32.38B $33.51B
Total Debt (incl. Leases) $31.16B $32.61B $34.05B $14.14B $12.94B $13.44B $13.24B $15.28B
Common Stock $25.64B $25.50B $25.35B $25.53B $25.41B $25.28B $25.12B $25.15B
Retained Earnings $49.64B $49.79B $49.96B $49.78B $49.10B $48.47B $47.72B $47.26B
Accumulated Other Comp. Income -$6.34B -$6.21B -$6.31B -$6.00B -$6.68B -$6.58B -$7.42B -$7.91B
Total Stockholders' Equity $51.03B $51.11B $52.06B $52.13B $50.95B $50.56B $48.81B $47.66B
Total Equity $51.62B $51.76B $52.70B $52.77B $51.26B $50.83B $49.06B $47.90B

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income $6.52B $13.40B $5.72B $6.93B $7.07B $4.50B $3.69B $2.37B $477.0M $1.40B
Depreciation & Amortization $3.12B $3.22B $3.24B $3.27B $3.54B $3.33B $3.01B $3.28B $3.02B $1.35B
Stock-Based Compensation $664.0M $673.0M $644.0M $685.0M $640.0M $546.0M $519.0M $477.0M $406.0M $310.0M
Change in Receivables -$652.0M -$691.0M -$356.0M -$68.00M -$383.0M -$924.0M -$275.0M -$190.0M -$207.0M -$177.0M
Change in Inventory $195.0M -$58.00M -$232.0M -$1.41B -$456.0M -$493.0M -$593.0M -$514.0M $249.0M -$98.00M
Operating Cash Flow $9.57B $8.56B $7.26B $9.58B $10.53B $7.90B $6.14B $6.30B $5.57B $3.20B
Capital Expenditure -$2.17B -$2.21B -$2.20B -$1.78B -$1.89B -$2.18B -$1.64B -$1.39B -$1.14B -$1.12B
Free Cash Flow $7.39B $6.35B $5.06B $7.80B $8.65B $5.72B $4.50B $4.91B $4.43B $2.08B
Acquisitions, Net -- -- -- -- -- -- -- -- -$17.18B -$80.00M
Purchases of Investments -$167.0M -$169.0M -$159.0M -$185.0M -$173.0M -$83.00M -$103.0M -$131.0M -$210.0M -$2.82B
Investing Cash Flow -$2.42B -$2.34B -$3.13B -$1.74B -$2.01B -$2.21B -$1.81B -$1.36B -$9.62B -$248.0M
Share Repurchases -$893.0M -$1.29B -$1.23B -$3.79B -$2.30B -$403.0M -$718.0M -$238.0M -$117.0M -$522.0M
Dividends Paid -$4.12B -$3.84B -$3.56B -$3.31B -$3.20B -$2.56B -$2.27B -$1.97B -$1.85B -$1.54B
Financing Cash Flow -$6.31B -$5.40B -$7.09B -$7.64B -$5.49B -$2.78B -$4.29B -$10.39B -$5.28B $11.15B
Net Change in Cash $906.0M $720.0M -$2.99B $83.00M $2.96B $2.98B $16.00M -$5.56B -$9.21B $13.62B

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income $920.0M $928.0M $1.08B $1.78B $1.64B $1.78B $1.32B $9.23B
Depreciation & Amortization $1.26B $1.06B $803.0M $792.0M $791.0M $777.0M $756.0M $807.0M
Stock-Based Compensation $137.0M $168.0M $317.0M $113.0M $120.0M $142.0M $289.0M $111.0M
Change in Receivables -$476.0M -$386.0M -$42.00M $222.0M -$202.0M -$410.0M -$262.0M -$158.0M
Change in Inventory -$51.00M -$301.0M -$420.0M $234.0M $213.0M $3.00M -$255.0M $235.0M
Operating Cash Flow $1.74B $2.49B $1.31B $3.31B $2.79B $2.05B $1.42B $2.87B
Capital Expenditure -$513.0M -$497.0M -$399.0M -$689.0M -$496.0M -$502.0M -$484.0M -$720.0M
Free Cash Flow $1.22B $1.99B $916.0M $2.63B $2.29B $1.54B $933.0M $2.15B
Investing Cash Flow -$385.0M -$673.0M -$20.32B -$913.0M -$457.0M -$582.0M -$470.0M -$866.0M
Share Repurchases -$11.00M -$1.04B -$180.0M -$302.0M -$305.0M -$6.00M -$280.0M -$315.0M
Dividends Paid -$1.09B -$1.10B -$1.10B -$1.03B -$1.03B -$1.03B -$1.03B -$958.0M
Financing Cash Flow -$2.40B -$3.52B $17.31B -$1.40B -$1.76B -$1.10B -$2.06B -$1.86B
Net Change in Cash -$1.05B -$1.70B -$1.72B $1.01B $560.0M $419.0M -$1.08B $58.00M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 56.4% 55.4% 55.2% 56.1% 57.0% 56.6% 58.5% 58.4% 54.7% 56.4%
Operating Margin 18.2% 16.3% 16.2% 19.2% 19.6% 15.5% 14.2% 11.9% 5.7% 14.5%
Net Profit Margin 14.7% 31.9% 14.3% 15.9% 16.4% 13.0% 11.6% 7.7% 1.7% 6.7%
Return on Equity (ROE) 12.5% 28.1% 14.8% 18.9% 19.8% 13.7% 11.9% 7.8% 1.5% 6.8%
Return on Assets (ROA) 7.5% 16.5% 7.8% 9.3% 9.4% 6.2% 5.4% 3.5% 0.6% 2.7%
Current Ratio 1.58x 1.67x 1.64x 1.63x 1.85x 1.72x 1.44x 1.62x 2.26x 4.02x
Quick Ratio 1.18x 1.23x 1.16x 1.23x 1.46x 1.30x 1.04x 1.20x 1.86x 3.65x
Debt to Equity 0.27x 0.32x 0.41x 0.49x 0.54x 0.61x 0.61x 0.64x 0.90x 1.07x
Revenue Growth (YoY) +5.7% +4.6% -8.1% +1.3% +24.5% +8.5% +4.3% +11.6% +31.3% +2.2%
Gross Profit Growth (YoY) +7.6% +5.0% -9.7% -0.1% +25.2% +5.0% +4.5% +19.3% +27.4% +0.9%
Operating Income Growth (YoY) +18.0% +5.4% -22.5% -0.7% +57.3% +18.2% +24.2% +133.4% -48.3% +5.5%
Net Income Growth (YoY) -51.3% +134.2% -17.5% -2.0% +57.3% +21.9% +55.7% +396.4% -65.9% -68.3%
EPS Growth (YoY) -51.4% +133.8% -16.8% -0.8% +57.5% +21.7% +54.5% +396.3% -71.3% -68.0%
Operating Cash Flow Growth (YoY) +11.8% +17.9% -24.2% -9.0% +33.3% +28.8% -2.6% +13.1% +73.9% +8.0%
Free Cash Flow Growth (YoY) +16.4% +25.5% -35.2% -9.8% +51.1% +27.3% -8.3% +10.6% +113.0% +12.2%
5Y Revenue / Share Growth +30.4% +33.6% +32.5% +58.2% +71.9% +43.1% +35.1% +37.9% +30.1% +2.7%
10Y Revenue / Share Growth +86.7% +80.5% +82.7% +105.9% +76.5% -14.2% -9.3% -9.0% -6.3% --
5Y Net Income / Share Growth +47.8% +269.3% +144.2% +1342.7% +320.3% -14.2% +38.4% -18.5% -92.8% -68.8%
10Y Net Income / Share Growth +26.7% +411.2% +98.9% +4.5% +31.2% -15.3% -43.9% -57.4% -88.3% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin 56.9% 56.6% 56.3% 56.4% 55.9% 56.0% 55.8% 55.4%
Operating Margin 13.8% 15.8% 17.1% 18.2% 17.6% 17.4% 16.8% 16.3%
Net Profit Margin 9.7% 11.6% 13.9% 14.7% 31.9% 32.4% 31.9% 31.9%
Return on Equity (ROE) 9.2% 10.6% 12.1% 12.5% 27.4% 27.6% 27.7% 28.1%
Return on Assets (ROA) 4.3% 5.0% 5.7% 7.5% 16.6% 16.6% 16.6% 16.5%
Current Ratio 1.45x 1.38x 1.39x 1.58x 1.70x 1.82x 1.78x 1.67x
Quick Ratio 1.00x 0.97x 1.01x 1.18x 1.24x 1.30x 1.27x 1.23x
Debt to Equity 0.61x 0.64x 0.65x 0.27x 0.25x 0.27x 0.27x 0.32x
Revenue Growth (YoY) +14.5% +13.0% +7.8% +4.4% +6.9% +7.4% +4.0% +7.2%
Gross Profit Growth (YoY) +17.3% +15.6% +6.5% +8.4% +6.0% +8.9% +7.1% +6.1%
Operating Income Growth (YoY) -34.0% -17.5% -20.6% +17.8% +10.7% +22.9% +22.2% +7.4%
Net Income Growth (YoY) -44.0% -47.8% -18.7% -80.8% -0.1% +36.6% +8.2% +479.0%
EPS Growth (YoY) -43.6% -48.0% -18.4% -- 0.0% +37.8% +8.6% --
Operating Cash Flow Growth (YoY) -37.7% +21.5% -7.2% +15.6% +3.0% +4.4% +38.2% -5.6%
Free Cash Flow Growth (YoY) -46.6% +28.9% -1.8% +22.3% +6.6% +8.3% +48.8% -5.9%
Source: SEC EDGAR CompanyFacts (CIK 0000001800) · from December 31, 2007 Data through September 30, 2026 · synced Nov 20, 2026, 05:00 UTC · Open in terminal